Arlington, MA, United States of America

Anne Pelz

This inventor holds 5 USPTO granted patents and 12 published patent applications. Top assignee: Cytel Corporation. Active years: 2024-2025.

USPTO Granted Patents = 5 

% Patents Active = 100.0

Average Co-Inventor Count = 12.0

ph-index = 2

Forward Citations = 7(Granted Patents)


Company Filing History:


Years Active: 2024-2025

Loading Chart...
5 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Anne Pelz

Introduction

Anne Pelz is a notable inventor based in Arlington, MA (US), recognized for her significant contributions to the field of trial design methodologies. With a total of 5 patents to her name, she has made strides in developing innovative solutions that enhance the efficiency and effectiveness of trial designs.

Latest Patents

Among her latest patents is a groundbreaking trial design platform. This method involves receiving trial design criteria and scenarios, generating simulation data based on these inputs, and determining optimality criteria for evaluating trial designs. The process includes searching for globally optimum designs and transmitting these findings, thereby streamlining the trial design process. Another patent focuses on obtaining simulation data for a set of trial designs, determining optimality criteria, and recommending globally optimum designs, further showcasing her expertise in this area.

Career Highlights

Anne Pelz is currently employed at Cytel Corporation, where she applies her innovative ideas to real-world challenges in trial design. Her work has been instrumental in advancing methodologies that improve trial outcomes and efficiency.

Collaborations

Throughout her career, Anne has collaborated with esteemed colleagues such as Jaydeep Bhattacharyya and James Bolognese, contributing to a dynamic and innovative work environment.

Conclusion

Anne Pelz's contributions to the field of trial design are noteworthy, and her innovative patents reflect her commitment to advancing methodologies that benefit the industry. Her work continues to influence the way trial designs are approached and executed.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…